These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2353502)

  • 41. Effect of restenosis after an earlier angioplasty at another coronary site on the frequency of restenosis after a subsequent coronary angioplasty.
    Berger PB; Bell MR; Holmes DR; Hammes L; Kosanke JL; Bresee SJ
    Am J Cardiol; 1992 Apr; 69(12):1086-9. PubMed ID: 1561984
    [No Abstract]   [Full Text] [Related]  

  • 42. [Self-expanding coronary endoprosthesis in the prevention of restenosis following transluminal angioplasty. Preliminary clinical study].
    Puel J; Joffre F; Rousseau H; Guermonprez JL; Lancelin B; Morice MC; Valeix B; Imbert C; Bounhoure JP
    Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1311-2. PubMed ID: 2961318
    [No Abstract]   [Full Text] [Related]  

  • 43. Multi-Hospital Eastern Atlantic Restenosis Trial: design, recruitment, and feasibility. M-HEART Investigators.
    Hill JA; Macdonald RG; Jugo R; Hirshfeld JW; Goldberg S; Savage MP; Vetrovec G; Cowley M; Bass TA; Margolis JR
    Cathet Cardiovasc Diagn; 1990 Aug; 20(4):227-37. PubMed ID: 2208249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Very early prediction of restenosis after successful coronary angioplasty: how early is early and can we identify it?
    Holmes DR
    J Am Coll Cardiol; 1990 Feb; 15(2):265-6. PubMed ID: 2299064
    [No Abstract]   [Full Text] [Related]  

  • 45. Restenosis following coronary angioplasty.
    Beatt KJ; Serruys PW
    Int J Card Imaging; 1990; 5(2-3):155-62. PubMed ID: 2230293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty.
    Freed M; Safian RD; O'Neill WW; Safian M; Jones D; Grines CL
    Am J Cardiol; 1995 Dec; 76(16):1185-8. PubMed ID: 7484908
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty.
    Chenu PC; Schroeder E; Krémer R; Marchandise B
    Am J Cardiol; 1993 Nov; 72(15):1209-11. PubMed ID: 8237819
    [No Abstract]   [Full Text] [Related]  

  • 48. Lipoprotein (a) is not a risk factor for restenosis after percutaneous transluminal coronary angioplasty.
    Schumacher M; Tiran A; Eber B; Toplak H; Wilders-Truschnig M; Klein W
    Am J Cardiol; 1992 Feb; 69(5):572. PubMed ID: 1531283
    [No Abstract]   [Full Text] [Related]  

  • 49. Restenosis: the "hole" truth?
    King SB
    J Am Coll Cardiol; 1995 Sep; 26(3):703. PubMed ID: 7642862
    [No Abstract]   [Full Text] [Related]  

  • 50. Costs of coronary restenosis (Lovastatin Restenosis Trial).
    Gilbert SP; Weintraub WS; Talley JD; Boccuzzi SJ
    Am J Cardiol; 1996 Jan; 77(2):196-9. PubMed ID: 8546093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Initial experiences with laser angioplasty in man: current status, limitations and future possibilities].
    Colombo A
    G Ital Cardiol; 1990 Aug; 20(8):729-33. PubMed ID: 2272420
    [No Abstract]   [Full Text] [Related]  

  • 52. Late angiographic status of coronary angioplasty site which was < 50% narrowed 4 to 12 months after successful angioplasty.
    Ghazzal ZM; King SB; Douglas JS; Weintraub WS
    Am J Cardiol; 1994 May; 73(12):892-4. PubMed ID: 8184815
    [No Abstract]   [Full Text] [Related]  

  • 53. Restenosis after coronary angioplasty.
    Hong MK; Mehran R; Mintz GS; Leon MB
    Curr Probl Cardiol; 1997 Jan; 22(1):1-36. PubMed ID: 9010615
    [No Abstract]   [Full Text] [Related]  

  • 54. Patient follow-up after angioplasty: the problems of assessing restenosis.
    Beatt KJ; de Feyter PJ; Serruys PW
    Eur Heart J; 1989 Dec; 10 Suppl G():2-8. PubMed ID: 2697562
    [No Abstract]   [Full Text] [Related]  

  • 55. Asymptomatic restenosis: should we (re)intervene? An unresolved dilemma.
    Deshpande NV; Serruys PW
    Am Heart J; 1998 Oct; 136(4 Pt 1):576-7. PubMed ID: 9778059
    [No Abstract]   [Full Text] [Related]  

  • 56. Restenosis following coronary angioplasty: current status.
    Hong MK
    Korean J Intern Med; 2001 Jun; 16(2):51-5. PubMed ID: 11590901
    [No Abstract]   [Full Text] [Related]  

  • 57. Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography.
    Gershlick AH; de Bono D
    Br Heart J; 1993 May; 69(5):469. PubMed ID: 8357393
    [No Abstract]   [Full Text] [Related]  

  • 58. Fish oil supplements and restenosis after percutaneous transluminal coronary angioplasty.
    Reis GJ; Pasternak RC
    Am J Cardiol; 1990 Aug; 66(3):385-6. PubMed ID: 2368688
    [No Abstract]   [Full Text] [Related]  

  • 59. Appropriate uses of angiographic follow-up in the evaluation of new technologies for coronary intervention.
    Baim DS; Kuntz RE
    Circulation; 1994 Nov; 90(5):2560-3. PubMed ID: 7955219
    [No Abstract]   [Full Text] [Related]  

  • 60. Does smoking cessation reduce the risk of restenosis following coronary angioplasty?
    Pell JP
    Heart; 2000 Sep; 84(3):233-4. PubMed ID: 10956278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.